Bifidobacteria – morphological and clinical characteristics, their role in health maintenance and prospects for application

Objective: To study current data on the morphological and clinical properties of bifidobacteria. To evaluate their role in the formation of the intestinal barrier, immune response, and maintenance of metabolic balance. Materials and Methods: This article analyzes current methods of personalized therapy using bifidobacteria. Particular attention is paid to the clinical significance of these bacteria, the potential use of probiotics, synbiotics, and postbiotics, as well as their role in the prevention and treatment of diseases in gastroenterology, hematology, and oncology. Results: Bifidobacteria possess unique morphological and physiological characteristics that determine their important role in maintaining human health. They are capable of fermenting carbohydrates, synthesizing short-chain fatty acids and vitamins, and forming stable biofilms, making them an important part of the normal microbiota. Bifidobacteria are essential immunomodulators, ensuring harmonious interaction between various components of the immune system. Bifidobacteria also perform a protective function, strengthening the intestinal barrier and preventing the development of infectious and inflammatory processes. Despite significant advances in knowledge, unresolved issues remain related to optimizing dosages, selecting microbial strains, and determining the optimal timing of their use in clinical practice. The development of personalized medicine, the use of synbiotics and postbiotics, and the integration of probiotic therapy into the comprehensive treatment of serious diseases are also key areas. Conclusion: Bifidobacteria are key members of the intestinal microbiota, performing a wide range of functions, from metabolic and trophic to immunomodulatory and barrier functions. Modern scientific research highlights their important role in the prevention and treatment of various diseases, including allergic, inflammatory, metabolic, and hematologic oncology.